Compounded Therapy Risks
Susan emphasizes the lack of data and patient safety concerns surrounding compounded therapies. Simon discusses potential misconceptions about breast cancer risks associated with hormone replacement interventions. Susan highlights the need for caution and transparency when prescribing compounded therapies.In this clip
From this podcast
The Proof with Simon Hill
Menopause masterclass (Part 1) | Endocrinologist and Professor Susan Davis
Related Questions